DCDerrick W. S. Chan

Derrick W. S. Chan

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Derrick W. S. Chan has a total of 5 co-authors. Here are the top co-authors by number of shared publications:

  • Anuradha P. Menon

    Department of Paediatrics, Children's Intensive Care, KK Women's and Children's Hospital, Singapore

    1 shared publication
  • Jan Hau Lee

    Department of Paediatrics, Children's Intensive Care, KK Women's and Children's Hospital, Singapore

    1 shared publication
  • Terrence Thomas

    Department of Paediatrics, Pediatric Neurology, KK Women's and Children's Hospital, Singapore

    1 shared publication
  • Wei Wei Tan

    Department of Pharmacy, KK Women's and Children's Hospital, Singapore, Singapore

    1 shared publication
  • Yoke Hwee Chan

    Department of Paediatrics, Children's Intensive Care, KK Women's and Children's Hospital, Singapore

    1 shared publication

Latest Publications

  • Open Access

    Use of Magnesium Sulfate Infusion for the Management of Febrile Illness-Related Epilepsy Syndrome

    by Wei Wei Tan, Derrick W. S. Chan, Jan Hau Lee, Terrence Thomas, Anuradha P. Menon, Yoke Hwee Chan

    Febrile illness-related epilepsy syndrome is a catastrophic epileptic encephalopathy that is highly refractory to most antiepileptic drugs leading to high morbidity and mortality. The authors report the use of a pediatric infusion protocol of continuous intravenous magnesium sulfate for the control of seizures in 2 children with febrile illness-related epilepsy syndrome refractory to multiple antiepileptic drugs in a pediatric intensive care unit of a tertiary care children’s hospital. Both patients, 2 and 16 years of age, respectively, were treated with continuous magnesium sulfate infusion. Serum magnesium concentrations ranging from 2.1 to 5 mmol/L were achieved. Seizure reduction and cessation were noted in 1 patient with magnesium more than 3.0 mmol/L. No significant adverse effects were observed. Magnesium sulfate infusions can be safely used in pediatric refractory status epilepticus. Magnesium sulfate can be considered in the management of children with febrile illness-related epilepsy syndrome.